Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: A multicenter prospective, randomized, open-label blinded end point trial
Latest Information Update: 12 May 2016
At a glance
- Drugs Cilostazol (Primary)
- Indications Cerebral vasospasm; Embolism and thrombosis; Subarachnoid haemorrhage
- Focus Therapeutic Use
- 29 Aug 2013 New trial record
- 01 Jan 2013 Primary endpoint 'Disease-occurrence-rate' has been met.